RedHawk Holdings Corp. announced that the Board of Directors has appointed Philip C. Spizale as Chief Executive Officer, effective June 8, 2020. Mr. Spizale replaces G. Darcy Klug who has served as the Company's Interim Chief Executive Officer since November 12, 2018. Mr. Klug will remain as the Company's Chairman of the Board and Chief Financial Officer. He joined RedHawk as a healthcare advisor to the Board in November 2017. He was appointed as a member of the Board effective on July 1, 2019 and serves as Chairman of the Company's Compensation Committee. He has more than 25 years of sales and management experience in the healthcare industry. Since he joined RedHawk's Board, he has assisted in developing the Company's marketing strategies for sales and distribution of its medical devices as well as identifying critical future business development opportunities that are currently under consideration. In the four years prior to joining RedHawk, he was the Chief Sales Officer of REVA Inc. Between 2003 and 2016, he held various senior sales and managerial positions with Concentra Inc., a national health care provider of a wide range of medical services to employers and patients, including urgent care, occupational medicine, physical therapy, primary care, and wellness programs. He earned a Master of Business Administration degree from Webster University in St. Louis, MO and a Bachelor of Arts degree in Communications from Loyola University in New Orleans, LA.